Main > ONCOLOGY (**) > Lung>NSCLC>MET>ALK+ *** > Treatment > CH. N. Ceritinib Cap. > (*) USA Approvals>>
(*) USA Approvals>>'s subsections
>First Line Treat.: 2017. 05.26
>Progressed on Crizotinib: 2014.04
(*) USA Approvals>>'s products
This section has no products